Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia

BACKGROUND: The Clinical Assessment Program and Teflaro® Utilization Registry is designed to collect information on the clinical use of ceftaroline fosamil in the Unites States. This report presents data on the treatment of patients with Staphylococcus aureus bacteremia (SAB) secondary to acute bact...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazquez, Jose A., Maggiore, Christy R., Cole, Phillip, Smith, Alexander, Jandourek, Alena, Friedland, H. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280277/
https://www.ncbi.nlm.nih.gov/pubmed/25574117
http://dx.doi.org/10.1097/IPC.0000000000000191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280277/
https://www.ncbi.nlm.nih.gov/pubmed/25574117
http://dx.doi.org/10.1097/IPC.0000000000000191

Ejemplares similares